Journal
THORAX
Volume 76, Issue 4, Pages 405-407Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2020-216377
Keywords
viral infection; pneumonia; clinical epidemiology
Categories
Ask authors/readers for more resources
The study assessed symptoms and their determinants 1.5-6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020. Findings showed that individuals reported fewer symptoms after 1.5-6 months compared to during the acute COVID-19 phase, with persistent symptoms being associated with the number of comorbidities and symptoms experienced during the acute phase.
This study assessed symptoms and their determinants 1.5-6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5-6 months than during COVID-19; median (IQR) 0 (0-2) versus 8 (6-11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available